Literature DB >> 9006935

Sp1 is a critical regulator of the Wilms' tumor-1 gene.

H T Cohen1, S A Bossone, G Zhu, G A McDonald, V P Sukhatme.   

Abstract

We performed deletion analysis of WT1-reporter constructs containing up to 24 kilobases of 5'-flanking and first intron WT1 sequence in stably transfected cultured cells as an unbiased approach to identify cis elements critical for WT1 transcription. Although not a tissue-specific element, a proximate 9-base pair CTC repeat accounted for approximately 80% of WT1 transcription in this assay. Enhancer activity of the element and mutated versions correlated completely with their ability to form a DNA-protein complex in gel shifts. Antibody supershift, oligonucleotide competition, and Southwestern studies indicated that the CTC-binding factor is the transcriptional activator Sp1. Sp1 binds the CTC repeat with an affinity, KD = 0.37 nM, at least as high as the consensus GC box. Similar CTC repeats are found in promoters of other growth-related genes. Because Sp1 is important for WT1 expression, we examined Sp1 immunohistochemistry in fetal and adult kidney. In a pattern that precedes that of WT1 message, Sp1 immunostaining was highest in uninduced mesenchyme, early tubules, developing podocytes, and mature glomeruli, but was minimal in mature proximal tubules. This work suggests abundant Sp1 may be a prerequisite for WT1 expression, and that Sp1 may have a wider role in nephrogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006935     DOI: 10.1074/jbc.272.5.2901

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.

Authors:  D Mukhopadhyay; B Knebelmann; H T Cohen; S Ananth; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 2.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

3.  TGF-β-activated kinase 1 is crucial in podocyte differentiation and glomerular capillary formation.

Authors:  Sung Il Kim; So-Young Lee; Zhibo Wang; Yan Ding; Nadeem Haque; Jiwang Zhang; Jing Zhou; Mary E Choi
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

4.  Sp3 regulates fas expression in lung epithelial cells.

Authors:  H Pang; K Miranda; A Fine
Journal:  Biochem J       Date:  1998-07-01       Impact factor: 3.857

5.  Overlapping DNA recognition motifs between Sp1 and a novel trans-acting factor within the wt1 tumour suppressor gene promoter.

Authors:  M T Discenza; M Dehbi; J Pelletier
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

6.  The role of NF-kappaB in the regulation of the expression of wilms tumor suppressor gene WT1.

Authors:  Y Chen; B R Williams
Journal:  Gene Expr       Date:  2000

7.  Krüppel -like factor 8 is a stress-responsive transcription factor that regulates expression of HuR.

Authors:  Suman Govindaraju; Beth S Lee
Journal:  Cell Physiol Biochem       Date:  2014-08-08

8.  TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.

Authors:  Toru Sakairi; Yoshifusa Abe; Jeffrey B Kopp
Journal:  Nephrol Dial Transplant       Date:  2011-03-04       Impact factor: 5.992

9.  Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.

Authors:  Yiqing Guo; Jesse Pace; Zhengzhe Li; Avi Ma'ayan; Zichen Wang; Monica P Revelo; Edward Chen; Xiangchen Gu; Ahmed Attalah; Yaqi Yang; Chelsea Estrada; Vincent W Yang; John C He; Sandeep K Mallipattu
Journal:  J Am Soc Nephrol       Date:  2018-08-24       Impact factor: 10.121

10.  Transcription factor Sp3 knockout mice display serious cardiac malformations.

Authors:  Pieter Fokko van Loo; Edris A F Mahtab; Lambertus J Wisse; Jun Hou; Frank Grosveld; Guntram Suske; Sjaak Philipsen; Adriana C Gittenberger-de Groot
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.